Open AccessMesenchymal Stem Cells for Treatment of Retinitis Pigmentosa: Short Review
Author(s) -
Antonio Florido
Publication year - 2021
Publication title -
hsoa journal of stem cells research, development and therapy
Language(s) - English
Resource type - Journals
ISSN - 2381-2060
DOI - 10.24966/srdt-2060/100066
Subject(s) - retinitis pigmentosa , mesenchymal stem cell , paracrine signalling , stem cell , medicine , biology , microbiology and biotechnology , retina , neuroscience , receptor
The management of retinitis pigmentosa (RP) and its progression has always been a difficult issue, but promising developments have been shown by the use of mesenchymal stem cells (MSCs). It has thus been evidenced how these cells have significant paracrine and immunomodulatory properties: they secrete trophic factors that stimulate RPE or that are similar to those produced by RPE.